Search For "medalliance"
"Revolutionizing Heart Care & Empowering Patients:" Sirolimus-Driven Ballo
Updated : 4 months, 1 week ago IST
San Francisco [US], November 19: In a defining chapter for global cardiovascular care, MedAlliance, the Swiss-based innovator behind the patented SELUTION Sirolimus Drug-Eluting Balloon (DEB), continues to transform the landscape of heart disease treatment following its acquisition by Cordis
Read More
MedAlliance, a Pioneering Medical Device Startup, acquired by Cordis of US
Updated : 2 years, 5 months ago IST
Geneva [Switzerland], October 6: MedAlliance, the visionary Swiss-based medical technology company, is delighted to announce the successful acquisition by Cordis, a transaction valued at USD 1.135 billion (Rs. ~ 10,000 Crores). This union represents a remarkable milestone in the realm of med
Read More
MedAlliance, a Pioneering Medical Device Startup, acquired by Cordis of US
Updated : 2 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 5: MedAlliance, the visionary Swiss-based medical technology company, is delighted to announce the successful acquisition by Cordis, a transaction valued at USD 1.135 billion (Rs. ~ 10,000 Crores). This union represents a remarkable milestone in the real
Read More
MedAlliance Acquired by Cordis for up to USD 1.135 Billion
Updated : 2 years, 5 months ago IST
Geneva [Switzerland], October 2: Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of USD 35M and a 2023 upfront closing payment of USD 200M, together with regulatory achievement milestones of up to USD 125M and commercial milestones of up t
Read More
MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTI
Updated : 2 years, 6 months ago IST
Geneva [Switzerland], September 15: MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now half way towards a planned 3,326 patients. SELUTION DeNovo compares the treatment strategy using a novel siroli
Read More
MedAlliance announces enrollment of First Patient in SELUTION SLR LOVE-DEB
Updated : 2 years, 6 months ago IST
Geneva [Switzerland], September 6: The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR™. This is a trial initiated by physicians at the Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, which i
Read More
Excellent 12-month results from SELUTION SFA trial presented at JET
Updated : 2 years, 9 months ago IST
Geneva [Switzerland], May 31: 12-month results from the SELUTION SFA trial have been presented at the Japan Endovascular Treatment (JET) Conference in Tokyo. The objective of this study was to assess the safety and efficacy of SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloo
Read More
MedAlliance enrolls first US patient into its third FDA IDE Study: SFA SEL
Updated : 2 years, 10 months ago IST
Geneva [Switzerland], May 5 (ANI/PRNewswire): The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr Arthur Lee at the Cardiac & Vascular Institute in Florida. This study evaluates SELUTION SLR™ in the treatment of occlusive disease of the superficial
Read More
Over 1,000 patients enrolled in Landmark SELUTION DeNovo Study
Updated : 3 years ago IST
Geneva [Switzerland], March 15 (ANI/PRNewswire): MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now a third of the way towards the target of 3,326 patients. SELUTION DeNovo compares the treatment st
Read More
MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SE
Updated : 3 years, 1 month ago IST
Geneva [Switzerland], January 26 (ANI/PRNewswire): The first US patient has been enrolled at MedStar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to support FDA approval. This milestone follows Investigational Device Exemption (IDE) approval in the US i
Read More
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE
Updated : 3 years, 2 months ago IST
Geneva [Switzerland], January 11 (ANI/PRNewswire): SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions.
Read More
Cordis to acquire MedAlliance
Updated : 3 years, 5 months ago IST
New Delhi [India], October 21 (ANI/ATK): MedAlliance, a Swiss-based med-tech company, has announced that the company is going to be acquired by Cordis with a USD 35 million starting investment, a USD 200 million upfront closing payment, regulatory achievement milestones of up to USD 125 mill
Read More